TIRZEPATIDE 10MG, 20MG OR 30MG

Tirzepatide is a synthetic peptide that acts as a dual GIP and GLP-1 receptor agonist, making it the first FDA-approved medication in its class. It is approved for specific indications including type 2 diabetes and chronic weight management. Tirzepatide is being studied for its effects on metabolic and endocrine pathways through activation of GIP and GLP-1 receptors. THIS IS NOT A MEDICATION NORT IS IT TO TREAT, DIAGNOSE OR CURE ANYTHING. This is strctly for research purposes only in-vitro study application.